Clinical Trial Methodology - Chen, Ding-Geng (Din)

. .

Auteur(s) : Chen, Ding-Geng (Din) - Peace, Karl E.

Editeur : Chapman And Hall/Crc

Langue : Anglais

Parution : 01/07/2010

Format : Moyen, de 350g à 1kg

Nombre de pages : 422.0

Expédition : 735

Dimensions : 25.2 x 15.5 x 2.7

ISBN : 1584889179

Résumé :
Drawing from the authors' courses on the subject as well as Peace's more than 30 years working in the pharmaceutical industry, Clinical Trial Methodology emphasizes the importance of statistical thinking in clinical research and presents the methodology as a key component of clinical research.

Biographie:

Karl E. Peace is the Georgia Cancer Coalition Distinguished Cancer Scholar, founding director of the Center for Biostatistics, and professor of biostatistics in the Jiann-Ping Hsu College of Public Health at Georgia Southern University.

Din Chen is the Karl E. Peace Endowed Eminent Scholar Chair in Biostatistics and professor of biostatistics in the Jiann-Ping Hsu College of Public Health at Georgia Southern University.

Sommaire:

Overview of Clinical Trial Methodology. Overview of the Drug Development Process and Regulation of Clinical Trials. Ethical Considerations in the Design and Conduct of Clinical Trials. Sample Size Considerations in Clinical Trials Pre-Market Approval. Sequential, Group Sequential, Stochastic Curtailment, and Adaptive Design Procedures in Clinical Trials. Biostatistical Aspects of the Protocol. The Statistical Analysis Plan. Pooling of Data from Multicenter Clinical Trials. Validity of Statistical Inference. Bioequivalence Clinical Trials. Dose and Frequency Determination from Phase II Clinical Trials in Stress Test-Induced Angina. Confirmation of Clinically Optimal Dosing in the Treatment of Duodenal Ulcers: A Phase III Dose Comparison Trial. Pivotal Proof-of-Efficacy Clinical Trials in the Prevention of NANSAID-Induced Gastric Ulceration. Clinical Trials in the Treatment of Alzheimer's Disease Based upon Enrichment Designs. A Clinical Trial to Establish Reduction of CHD Risk. Pivotal Proof-of-Efficacy Clinical Trials in the Treatment of Panic Disorder. Combination Clinical Trials. Monitoring Clinical Trials for Adverse Events. Index.

! informative discussions of mechanisms such as IND and NDA ! are unique strengths of this book, distinguishing it from the many other clinical trial texts available. ! Case studies ! are presented carefully ! The authors' writing style is disciplined, careful, and informative. ! this is a helpful and informative book, a nice reference to have for most biostatisticians working on clinical trials. --Mithat Gonen, Journal of Biopharmaceutical Statistics, 21, 2011 The book is an excellent overview predicated on the first author's seasoned experiences in designing, analyzing, and communicating the results of clinical trials across a broad number of medical disciplines. ! A nice introductory feature is the history of drug law and regulation, which helps to frame the subsequent statistical discussion nicely. ! The real-world examples that dominate the last few chapters are fantastic. ! There is nothing like a series of examples from an experienced clinical trialist to whet the appetite of those involved in the noble enterprise of medical (and more specifically pharmaceutical) research with the goal of improving the public's health. This book does an admirable job in giving the regulatory and statistical foundations for clinical trials, coupled with real-world examples of how statistical methodology has guided the development of important medicines. ! --Gregory Enas